A detailed history of Martin Currie LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Martin Currie LTD holds 15,733 shares of LLY stock, worth $12.5 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
15,733
Holding current value
$12.5 Million
% of portfolio
0.55%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $12.1 Million - $15.1 Million
15,733 New
15,733 $13.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Martin Currie LTD Portfolio

Follow Martin Currie LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

News

Stay updated on Martin Currie LTD with notifications on news.